apoptosis assay (Multi Sciences (Lianke) Biotech Co Ltd)
Structured Review
Apoptosis Assay, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 98/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+solution/Apoptosis+Positive+Control+Solution/pm39934701-115-2-20
Average 98 stars, based on 2 article reviews
Images
Related Articles
other:Article Title: Targeting PSMB5-induced PANoptosis in bladder cancer: multi-omics insights and TCM candidate discovery Article Snippet: Apoptosis was evaluated utilizing the Article Title: Long non-coding RNA RP11-196G11.6 inhibits neuroblastoma progression by regulating the miR-376a-3p/RYBP signaling axis Article Snippet: After incubation for 2 h at 37°C, the absorbance values of each well were determined at a wavelength of 450 nm using a microplate reader (cat. no. WD-2012B; Beijing Liuyi Biotechnology, Co., Ltd.). Article Title: Design, synthesis and verification of HPV16 and HPV18 multiple antigens peptides Article Snippet: Considering that U14/HPV18E6E7 cells carried GFP, the apoptosis assay was stained with Article Title: Design, synthesis and verification of HPV16 and HPV18 multiple antigens peptides. Article Snippet: Considering that U14/HPV18E6E7 cells carried GFP, the apoptosis assay was stained with Positive Control:Article Title: Discovery of WWZ-11-098: a rigid and selective CDK6 degrader. Article Snippet: Dysregulation of the cell cycle, a hallmark of cancer, frequently involves aberrant activation of cyclin D-CDK4/6 complexes.. Although dual-CDK4/6 inhibitors are effective in advanced hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, CDK6 is preferentially expressed and functionally upregulated in hematologic malignancies, making it a promising therapeutic target.. The high structural homology between CDK4 and CDK6, however, has made developing selective CDK6 inhibitors exceptionally difficult. Incubation:Article Title: Discovery of WWZ-11-098: a rigid and selective CDK6 degrader. Article Snippet: Dysregulation of the cell cycle, a hallmark of cancer, frequently involves aberrant activation of cyclin D-CDK4/6 complexes.. Although dual-CDK4/6 inhibitors are effective in advanced hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, CDK6 is preferentially expressed and functionally upregulated in hematologic malignancies, making it a promising therapeutic target.. The high structural homology between CDK4 and CDK6, however, has made developing selective CDK6 inhibitors exceptionally difficult. Cell-Signaling:Article Title: Clostridium perfringens alpha toxin drives pathological NETosis via immature neutrophil mobilization and functional reprogramming Article Snippet: .. |

